nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—SLC15A2—multiple sclerosis	0.346	0.823	CbGaD
Glyburide—ALB—multiple sclerosis	0.0746	0.177	CbGaD
Glyburide—ABCC1—Mitoxantrone—multiple sclerosis	0.0327	0.0792	CbGbCtD
Glyburide—ABCG2—Cladribine—multiple sclerosis	0.03	0.0726	CbGbCtD
Glyburide—SLCO1A2—Prednisolone—multiple sclerosis	0.0257	0.0622	CbGbCtD
Glyburide—SLCO1A2—Prednisone—multiple sclerosis	0.0242	0.0587	CbGbCtD
Glyburide—ABCB11—Dexamethasone—multiple sclerosis	0.0239	0.0578	CbGbCtD
Glyburide—ABCC3—Methotrexate—multiple sclerosis	0.0222	0.0537	CbGbCtD
Glyburide—ABCG2—Mitoxantrone—multiple sclerosis	0.0219	0.053	CbGbCtD
Glyburide—SLC22A7—Methotrexate—multiple sclerosis	0.0173	0.042	CbGbCtD
Glyburide—SLCO1A2—Dexamethasone—multiple sclerosis	0.0151	0.0366	CbGbCtD
Glyburide—ABCC1—Methotrexate—multiple sclerosis	0.0136	0.033	CbGbCtD
Glyburide—ABCC2—Dexamethasone—multiple sclerosis	0.0125	0.0304	CbGbCtD
Glyburide—ALB—Prednisone—multiple sclerosis	0.0125	0.0303	CbGbCtD
Glyburide—SLCO1A2—Methotrexate—multiple sclerosis	0.0122	0.0294	CbGbCtD
Glyburide—ABCG2—Dexamethasone—multiple sclerosis	0.0113	0.0275	CbGbCtD
Glyburide—ABCB1—Methylprednisolone—multiple sclerosis	0.0108	0.0262	CbGbCtD
Glyburide—ABCC2—Methotrexate—multiple sclerosis	0.0101	0.0244	CbGbCtD
Glyburide—CYP3A4—Fingolimod—multiple sclerosis	0.0101	0.0243	CbGbCtD
Glyburide—ABCG2—Methotrexate—multiple sclerosis	0.00912	0.0221	CbGbCtD
Glyburide—CYP2C19—Prednisone—multiple sclerosis	0.00812	0.0197	CbGbCtD
Glyburide—ABCB1—Mitoxantrone—multiple sclerosis	0.00789	0.0191	CbGbCtD
Glyburide—SLC22A6—Methotrexate—multiple sclerosis	0.00738	0.0179	CbGbCtD
Glyburide—ABCB1—Betamethasone—multiple sclerosis	0.00703	0.017	CbGbCtD
Glyburide—ABCB1—Prednisolone—multiple sclerosis	0.00694	0.0168	CbGbCtD
Glyburide—ABCB1—Prednisone—multiple sclerosis	0.00655	0.0159	CbGbCtD
Glyburide—CYP3A4—Methylprednisolone—multiple sclerosis	0.00648	0.0157	CbGbCtD
Glyburide—ALB—Methotrexate—multiple sclerosis	0.00628	0.0152	CbGbCtD
Glyburide—CYP2C19—Dexamethasone—multiple sclerosis	0.00507	0.0123	CbGbCtD
Glyburide—CYP3A4—Triamcinolone—multiple sclerosis	0.00491	0.0119	CbGbCtD
Glyburide—CYP3A4—Mitoxantrone—multiple sclerosis	0.00473	0.0114	CbGbCtD
Glyburide—CYP2C9—Dexamethasone—multiple sclerosis	0.00421	0.0102	CbGbCtD
Glyburide—CYP3A4—Betamethasone—multiple sclerosis	0.00421	0.0102	CbGbCtD
Glyburide—CYP3A4—Prednisolone—multiple sclerosis	0.00416	0.0101	CbGbCtD
Glyburide—ABCB1—Dexamethasone—multiple sclerosis	0.00409	0.0099	CbGbCtD
Glyburide—CYP3A4—Prednisone—multiple sclerosis	0.00393	0.0095	CbGbCtD
Glyburide—ABCB1—Methotrexate—multiple sclerosis	0.00329	0.00796	CbGbCtD
Glyburide—CYP3A4—Dexamethasone—multiple sclerosis	0.00245	0.00593	CbGbCtD
Glyburide—KCNJ5—brainstem—multiple sclerosis	0.00224	0.081	CbGeAlD
Glyburide—KCNJ5—nervous system—multiple sclerosis	0.00117	0.0424	CbGeAlD
Glyburide—KCNJ5—central nervous system—multiple sclerosis	0.00113	0.0409	CbGeAlD
Glyburide—KCNJ5—cerebellum—multiple sclerosis	0.00111	0.0399	CbGeAlD
Glyburide—Chlorpropamide—SLC15A2—multiple sclerosis	0.000928	0.473	CrCbGaD
Glyburide—KCNJ5—brain—multiple sclerosis	0.000898	0.0324	CbGeAlD
Glyburide—Sulpiride—BCHE—multiple sclerosis	0.000776	0.396	CrCbGaD
Glyburide—ABCA1—spinal cord—multiple sclerosis	0.000716	0.0259	CbGeAlD
Glyburide—ABCC9—brain—multiple sclerosis	0.00068	0.0246	CbGeAlD
Glyburide—ABCC8—brainstem—multiple sclerosis	0.000676	0.0244	CbGeAlD
Glyburide—KCNJ1—nervous system—multiple sclerosis	0.000634	0.0229	CbGeAlD
Glyburide—KCNJ1—central nervous system—multiple sclerosis	0.000611	0.0221	CbGeAlD
Glyburide—CPT1A—cerebellum—multiple sclerosis	0.00061	0.022	CbGeAlD
Glyburide—ABCA1—nervous system—multiple sclerosis	0.000603	0.0218	CbGeAlD
Glyburide—ABCA1—central nervous system—multiple sclerosis	0.000581	0.021	CbGeAlD
Glyburide—ABCA1—cerebellum—multiple sclerosis	0.000568	0.0205	CbGeAlD
Glyburide—CPT1A—brain—multiple sclerosis	0.000495	0.0179	CbGeAlD
Glyburide—KCNJ1—brain—multiple sclerosis	0.000485	0.0175	CbGeAlD
Glyburide—ABCC8—medulla oblongata—multiple sclerosis	0.000472	0.017	CbGeAlD
Glyburide—ABCA1—brain—multiple sclerosis	0.000461	0.0167	CbGeAlD
Glyburide—CFTR—brain—multiple sclerosis	0.000436	0.0157	CbGeAlD
Glyburide—ABCC8—midbrain—multiple sclerosis	0.000431	0.0156	CbGeAlD
Glyburide—ABCC8—spinal cord—multiple sclerosis	0.000421	0.0152	CbGeAlD
Glyburide—SLC15A2—retina—multiple sclerosis	0.00039	0.0141	CbGeAlD
Glyburide—KCNJ11—nervous system—multiple sclerosis	0.000385	0.0139	CbGeAlD
Glyburide—KCNJ11—central nervous system—multiple sclerosis	0.00037	0.0134	CbGeAlD
Glyburide—SLCO2B1—medulla oblongata—multiple sclerosis	0.000369	0.0133	CbGeAlD
Glyburide—KCNJ11—cerebellum—multiple sclerosis	0.000362	0.0131	CbGeAlD
Glyburide—ABCC8—nervous system—multiple sclerosis	0.000354	0.0128	CbGeAlD
Glyburide—ABCC8—central nervous system—multiple sclerosis	0.000341	0.0123	CbGeAlD
Glyburide—SLCO1A2—medulla oblongata—multiple sclerosis	0.00034	0.0123	CbGeAlD
Glyburide—ABCC8—cerebellum—multiple sclerosis	0.000334	0.0121	CbGeAlD
Glyburide—SLCO2B1—spinal cord—multiple sclerosis	0.000329	0.0119	CbGeAlD
Glyburide—SLC22A7—brain—multiple sclerosis	0.000322	0.0116	CbGeAlD
Glyburide—SLC22A6—brain—multiple sclerosis	0.000311	0.0112	CbGeAlD
Glyburide—SLCO1A2—midbrain—multiple sclerosis	0.000311	0.0112	CbGeAlD
Glyburide—SLCO1A2—spinal cord—multiple sclerosis	0.000303	0.0109	CbGeAlD
Glyburide—ABCC3—nervous system—multiple sclerosis	0.000298	0.0108	CbGeAlD
Glyburide—KCNJ11—brain—multiple sclerosis	0.000294	0.0106	CbGeAlD
Glyburide—ABCC3—central nervous system—multiple sclerosis	0.000287	0.0104	CbGeAlD
Glyburide—SLC15A2—medulla oblongata—multiple sclerosis	0.000282	0.0102	CbGeAlD
Glyburide—SLCO2B1—nervous system—multiple sclerosis	0.000277	0.01	CbGeAlD
Glyburide—ABCC8—brain—multiple sclerosis	0.000271	0.00979	CbGeAlD
Glyburide—SLCO2B1—central nervous system—multiple sclerosis	0.000267	0.00965	CbGeAlD
Glyburide—SLCO2B1—cerebellum—multiple sclerosis	0.000261	0.00943	CbGeAlD
Glyburide—SLC15A2—midbrain—multiple sclerosis	0.000258	0.00931	CbGeAlD
Glyburide—Gliclazide—ALB—multiple sclerosis	0.000257	0.131	CrCbGaD
Glyburide—SLCO1A2—nervous system—multiple sclerosis	0.000255	0.00922	CbGeAlD
Glyburide—SLC15A2—spinal cord—multiple sclerosis	0.000251	0.00908	CbGeAlD
Glyburide—SLCO1A2—central nervous system—multiple sclerosis	0.000246	0.00888	CbGeAlD
Glyburide—SLCO1A2—cerebellum—multiple sclerosis	0.00024	0.00868	CbGeAlD
Glyburide—ABCG2—medulla oblongata—multiple sclerosis	0.000231	0.00834	CbGeAlD
Glyburide—ABCC3—brain—multiple sclerosis	0.000227	0.00822	CbGeAlD
Glyburide—SLCO2B1—brain—multiple sclerosis	0.000212	0.00766	CbGeAlD
Glyburide—SLC15A2—nervous system—multiple sclerosis	0.000212	0.00765	CbGeAlD
Glyburide—ABCG2—midbrain—multiple sclerosis	0.000211	0.00762	CbGeAlD
Glyburide—ABCG2—spinal cord—multiple sclerosis	0.000206	0.00744	CbGeAlD
Glyburide—SLC15A2—central nervous system—multiple sclerosis	0.000204	0.00737	CbGeAlD
Glyburide—SLC15A2—cerebellum—multiple sclerosis	0.000199	0.0072	CbGeAlD
Glyburide—ABCC1—cerebellum—multiple sclerosis	0.000197	0.00712	CbGeAlD
Glyburide—SLCO1A2—brain—multiple sclerosis	0.000195	0.00705	CbGeAlD
Glyburide—ALB—brain—multiple sclerosis	0.000194	0.00701	CbGeAlD
Glyburide—Pruritus—Cladribine—multiple sclerosis	0.000174	0.0023	CcSEcCtD
Glyburide—Visual disturbance—Methotrexate—multiple sclerosis	0.000173	0.00229	CcSEcCtD
Glyburide—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000173	0.00229	CcSEcCtD
Glyburide—Convulsion—Mitoxantrone—multiple sclerosis	0.000172	0.00227	CcSEcCtD
Glyburide—Abdominal distension—Prednisone—multiple sclerosis	0.000171	0.00226	CcSEcCtD
Glyburide—Myalgia—Mitoxantrone—multiple sclerosis	0.000169	0.00223	CcSEcCtD
Glyburide—Arthralgia—Mitoxantrone—multiple sclerosis	0.000169	0.00223	CcSEcCtD
Glyburide—Diarrhoea—Cladribine—multiple sclerosis	0.000169	0.00223	CcSEcCtD
Glyburide—Pancreatitis—Prednisone—multiple sclerosis	0.000166	0.0022	CcSEcCtD
Glyburide—Sweating increased—Prednisone—multiple sclerosis	0.000165	0.00219	CcSEcCtD
Glyburide—Visual impairment—Methylprednisolone—multiple sclerosis	0.000165	0.00218	CcSEcCtD
Glyburide—Feeling abnormal—Azathioprine—multiple sclerosis	0.000165	0.00218	CcSEcCtD
Glyburide—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000164	0.00216	CcSEcCtD
Glyburide—Confusional state—Mitoxantrone—multiple sclerosis	0.000163	0.00216	CcSEcCtD
Glyburide—ABCG2—cerebellum—multiple sclerosis	0.000163	0.0059	CbGeAlD
Glyburide—Erythema—Prednisolone—multiple sclerosis	0.000163	0.00215	CcSEcCtD
Glyburide—SLC15A2—brain—multiple sclerosis	0.000162	0.00585	CbGeAlD
Glyburide—Oedema—Mitoxantrone—multiple sclerosis	0.000162	0.00214	CcSEcCtD
Glyburide—Eye disorder—Methylprednisolone—multiple sclerosis	0.00016	0.00212	CcSEcCtD
Glyburide—ABCC1—brain—multiple sclerosis	0.00016	0.00579	CbGeAlD
Glyburide—Shock—Mitoxantrone—multiple sclerosis	0.000159	0.00211	CcSEcCtD
Glyburide—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000159	0.00209	CcSEcCtD
Glyburide—Abdominal pain—Azathioprine—multiple sclerosis	0.000158	0.00209	CcSEcCtD
Glyburide—ABCB1—retina—multiple sclerosis	0.000157	0.00569	CbGeAlD
Glyburide—Vomiting—Cladribine—multiple sclerosis	0.000157	0.00207	CcSEcCtD
Glyburide—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000157	0.00207	CcSEcCtD
Glyburide—Rash—Cladribine—multiple sclerosis	0.000155	0.00205	CcSEcCtD
Glyburide—Dermatitis—Cladribine—multiple sclerosis	0.000155	0.00205	CcSEcCtD
Glyburide—Anorexia—Mitoxantrone—multiple sclerosis	0.000154	0.00204	CcSEcCtD
Glyburide—Headache—Cladribine—multiple sclerosis	0.000154	0.00204	CcSEcCtD
Glyburide—Vision blurred—Prednisolone—multiple sclerosis	0.000153	0.00203	CcSEcCtD
Glyburide—Hypotension—Mitoxantrone—multiple sclerosis	0.000151	0.002	CcSEcCtD
Glyburide—Visual impairment—Betamethasone—multiple sclerosis	0.00015	0.00199	CcSEcCtD
Glyburide—Visual impairment—Dexamethasone—multiple sclerosis	0.00015	0.00199	CcSEcCtD
Glyburide—Erythema—Triamcinolone—multiple sclerosis	0.00015	0.00198	CcSEcCtD
Glyburide—Erythema—Methylprednisolone—multiple sclerosis	0.000149	0.00197	CcSEcCtD
Glyburide—Malnutrition—Methylprednisolone—multiple sclerosis	0.000149	0.00197	CcSEcCtD
Glyburide—Angioedema—Prednisolone—multiple sclerosis	0.000149	0.00197	CcSEcCtD
Glyburide—Hypersensitivity—Azathioprine—multiple sclerosis	0.000148	0.00195	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000147	0.00195	CcSEcCtD
Glyburide—Nausea—Cladribine—multiple sclerosis	0.000146	0.00193	CcSEcCtD
Glyburide—Eye disorder—Betamethasone—multiple sclerosis	0.000146	0.00193	CcSEcCtD
Glyburide—Eye disorder—Dexamethasone—multiple sclerosis	0.000146	0.00193	CcSEcCtD
Glyburide—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000145	0.00192	CcSEcCtD
Glyburide—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000144	0.00191	CcSEcCtD
Glyburide—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000143	0.00188	CcSEcCtD
Glyburide—Convulsion—Prednisolone—multiple sclerosis	0.000141	0.00186	CcSEcCtD
Glyburide—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000141	0.00186	CcSEcCtD
Glyburide—Eosinophilia—Methotrexate—multiple sclerosis	0.00014	0.00186	CcSEcCtD
Glyburide—Pancreatitis—Methotrexate—multiple sclerosis	0.000139	0.00184	CcSEcCtD
Glyburide—Alopecia—Betamethasone—multiple sclerosis	0.000138	0.00182	CcSEcCtD
Glyburide—Alopecia—Dexamethasone—multiple sclerosis	0.000138	0.00182	CcSEcCtD
Glyburide—Diarrhoea—Azathioprine—multiple sclerosis	0.000137	0.00181	CcSEcCtD
Glyburide—Angioedema—Triamcinolone—multiple sclerosis	0.000137	0.00181	CcSEcCtD
Glyburide—Angioedema—Methylprednisolone—multiple sclerosis	0.000136	0.0018	CcSEcCtD
Glyburide—Erythema—Betamethasone—multiple sclerosis	0.000136	0.00179	CcSEcCtD
Glyburide—Erythema—Dexamethasone—multiple sclerosis	0.000136	0.00179	CcSEcCtD
Glyburide—Pancytopenia—Methotrexate—multiple sclerosis	0.000135	0.00178	CcSEcCtD
Glyburide—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000133	0.00176	CcSEcCtD
Glyburide—Oedema—Prednisolone—multiple sclerosis	0.000133	0.00176	CcSEcCtD
Glyburide—ABCG2—brain—multiple sclerosis	0.000133	0.00479	CbGeAlD
Glyburide—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000132	0.00175	CcSEcCtD
Glyburide—Shock—Prednisolone—multiple sclerosis	0.000131	0.00173	CcSEcCtD
Glyburide—Convulsion—Triamcinolone—multiple sclerosis	0.00013	0.00171	CcSEcCtD
Glyburide—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000129	0.00171	CcSEcCtD
Glyburide—Convulsion—Methylprednisolone—multiple sclerosis	0.000129	0.00171	CcSEcCtD
Glyburide—Urticaria—Mitoxantrone—multiple sclerosis	0.000129	0.0017	CcSEcCtD
Glyburide—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000128	0.0017	CcSEcCtD
Glyburide—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000128	0.00169	CcSEcCtD
Glyburide—Myalgia—Triamcinolone—multiple sclerosis	0.000127	0.00168	CcSEcCtD
Glyburide—Vomiting—Azathioprine—multiple sclerosis	0.000127	0.00168	CcSEcCtD
Glyburide—Arthralgia—Methylprednisolone—multiple sclerosis	0.000127	0.00168	CcSEcCtD
Glyburide—Myalgia—Methylprednisolone—multiple sclerosis	0.000127	0.00168	CcSEcCtD
Glyburide—Eye disorder—Prednisone—multiple sclerosis	0.000127	0.00168	CcSEcCtD
Glyburide—Rash—Azathioprine—multiple sclerosis	0.000126	0.00167	CcSEcCtD
Glyburide—Dermatitis—Azathioprine—multiple sclerosis	0.000126	0.00167	CcSEcCtD
Glyburide—Headache—Azathioprine—multiple sclerosis	0.000125	0.00166	CcSEcCtD
Glyburide—Angioedema—Betamethasone—multiple sclerosis	0.000124	0.00164	CcSEcCtD
Glyburide—Angioedema—Dexamethasone—multiple sclerosis	0.000124	0.00164	CcSEcCtD
Glyburide—Confusional state—Methylprednisolone—multiple sclerosis	0.000123	0.00162	CcSEcCtD
Glyburide—Oedema—Triamcinolone—multiple sclerosis	0.000122	0.00161	CcSEcCtD
Glyburide—CYP3A4—nervous system—multiple sclerosis	0.000121	0.00437	CbGeAlD
Glyburide—Shock—Triamcinolone—multiple sclerosis	0.00012	0.00159	CcSEcCtD
Glyburide—Alopecia—Prednisone—multiple sclerosis	0.00012	0.00159	CcSEcCtD
Glyburide—Shock—Methylprednisolone—multiple sclerosis	0.00012	0.00158	CcSEcCtD
Glyburide—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00012	0.00158	CcSEcCtD
Glyburide—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000119	0.00158	CcSEcCtD
Glyburide—Paraesthesia—Prednisolone—multiple sclerosis	0.000119	0.00158	CcSEcCtD
Glyburide—Nausea—Azathioprine—multiple sclerosis	0.000119	0.00157	CcSEcCtD
Glyburide—Malnutrition—Prednisone—multiple sclerosis	0.000118	0.00156	CcSEcCtD
Glyburide—Erythema—Prednisone—multiple sclerosis	0.000118	0.00156	CcSEcCtD
Glyburide—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000118	0.00156	CcSEcCtD
Glyburide—Agranulocytosis—Methotrexate—multiple sclerosis	0.000118	0.00156	CcSEcCtD
Glyburide—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000118	0.00156	CcSEcCtD
Glyburide—Convulsion—Dexamethasone—multiple sclerosis	0.000118	0.00155	CcSEcCtD
Glyburide—Convulsion—Betamethasone—multiple sclerosis	0.000118	0.00155	CcSEcCtD
Glyburide—CYP3A4—central nervous system—multiple sclerosis	0.000116	0.0042	CbGeAlD
Glyburide—Asthenia—Mitoxantrone—multiple sclerosis	0.000116	0.00154	CcSEcCtD
Glyburide—Myalgia—Dexamethasone—multiple sclerosis	0.000116	0.00153	CcSEcCtD
Glyburide—Myalgia—Betamethasone—multiple sclerosis	0.000116	0.00153	CcSEcCtD
Glyburide—Hypotension—Methylprednisolone—multiple sclerosis	0.000114	0.00151	CcSEcCtD
Glyburide—ABCB1—medulla oblongata—multiple sclerosis	0.000114	0.00411	CbGeAlD
Glyburide—Hepatitis—Methotrexate—multiple sclerosis	0.000114	0.0015	CcSEcCtD
Glyburide—Vision blurred—Prednisone—multiple sclerosis	0.000111	0.00147	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000111	0.00147	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000111	0.00147	CcSEcCtD
Glyburide—Oedema—Dexamethasone—multiple sclerosis	0.000111	0.00146	CcSEcCtD
Glyburide—Oedema—Betamethasone—multiple sclerosis	0.000111	0.00146	CcSEcCtD
Glyburide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000111	0.00146	CcSEcCtD
Glyburide—Paraesthesia—Triamcinolone—multiple sclerosis	0.00011	0.00145	CcSEcCtD
Glyburide—Feeling abnormal—Prednisolone—multiple sclerosis	0.000109	0.00145	CcSEcCtD
Glyburide—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000109	0.00145	CcSEcCtD
Glyburide—Visual impairment—Methotrexate—multiple sclerosis	0.000109	0.00145	CcSEcCtD
Glyburide—Anaemia—Prednisone—multiple sclerosis	0.000109	0.00144	CcSEcCtD
Glyburide—Shock—Betamethasone—multiple sclerosis	0.000109	0.00144	CcSEcCtD
Glyburide—Shock—Dexamethasone—multiple sclerosis	0.000109	0.00144	CcSEcCtD
Glyburide—Dyspnoea—Triamcinolone—multiple sclerosis	0.000109	0.00144	CcSEcCtD
Glyburide—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000109	0.00144	CcSEcCtD
Glyburide—Nervous system disorder—Betamethasone—multiple sclerosis	0.000109	0.00144	CcSEcCtD
Glyburide—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000109	0.00143	CcSEcCtD
Glyburide—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000109	0.00143	CcSEcCtD
Glyburide—Angioedema—Prednisone—multiple sclerosis	0.000108	0.00143	CcSEcCtD
Glyburide—Dyspepsia—Triamcinolone—multiple sclerosis	0.000108	0.00142	CcSEcCtD
Glyburide—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000107	0.00142	CcSEcCtD
Glyburide—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000107	0.00142	CcSEcCtD
Glyburide—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000107	0.00142	CcSEcCtD
Glyburide—Eye disorder—Methotrexate—multiple sclerosis	0.000106	0.0014	CcSEcCtD
Glyburide—Anorexia—Betamethasone—multiple sclerosis	0.000106	0.0014	CcSEcCtD
Glyburide—Anorexia—Dexamethasone—multiple sclerosis	0.000106	0.0014	CcSEcCtD
Glyburide—Urticaria—Prednisolone—multiple sclerosis	0.000106	0.00139	CcSEcCtD
Glyburide—ABCB1—midbrain—multiple sclerosis	0.000104	0.00376	CbGeAlD
Glyburide—Hypotension—Betamethasone—multiple sclerosis	0.000104	0.00137	CcSEcCtD
Glyburide—Hypotension—Dexamethasone—multiple sclerosis	0.000104	0.00137	CcSEcCtD
Glyburide—Vomiting—Mitoxantrone—multiple sclerosis	0.000103	0.00136	CcSEcCtD
Glyburide—Convulsion—Prednisone—multiple sclerosis	0.000102	0.00135	CcSEcCtD
Glyburide—Rash—Mitoxantrone—multiple sclerosis	0.000102	0.00135	CcSEcCtD
Glyburide—Dermatitis—Mitoxantrone—multiple sclerosis	0.000102	0.00135	CcSEcCtD
Glyburide—ABCB1—spinal cord—multiple sclerosis	0.000101	0.00367	CbGeAlD
Glyburide—Headache—Mitoxantrone—multiple sclerosis	0.000101	0.00134	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000101	0.00133	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000101	0.00133	CcSEcCtD
Glyburide—Arthralgia—Prednisone—multiple sclerosis	0.000101	0.00133	CcSEcCtD
Glyburide—Myalgia—Prednisone—multiple sclerosis	0.000101	0.00133	CcSEcCtD
Glyburide—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000101	0.00133	CcSEcCtD
Glyburide—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.0001	0.00133	CcSEcCtD
Glyburide—Alopecia—Methotrexate—multiple sclerosis	0.0001	0.00133	CcSEcCtD
Glyburide—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	9.97e-05	0.00132	CcSEcCtD
Glyburide—Paraesthesia—Dexamethasone—multiple sclerosis	9.95e-05	0.00132	CcSEcCtD
Glyburide—Paraesthesia—Betamethasone—multiple sclerosis	9.95e-05	0.00132	CcSEcCtD
Glyburide—Erythema—Methotrexate—multiple sclerosis	9.88e-05	0.00131	CcSEcCtD
Glyburide—Malnutrition—Methotrexate—multiple sclerosis	9.88e-05	0.00131	CcSEcCtD
Glyburide—Hypersensitivity—Prednisolone—multiple sclerosis	9.79e-05	0.00129	CcSEcCtD
Glyburide—Dyspepsia—Dexamethasone—multiple sclerosis	9.76e-05	0.00129	CcSEcCtD
Glyburide—Dyspepsia—Betamethasone—multiple sclerosis	9.76e-05	0.00129	CcSEcCtD
Glyburide—Urticaria—Triamcinolone—multiple sclerosis	9.7e-05	0.00128	CcSEcCtD
Glyburide—Urticaria—Methylprednisolone—multiple sclerosis	9.68e-05	0.00128	CcSEcCtD
Glyburide—Oedema—Prednisone—multiple sclerosis	9.65e-05	0.00128	CcSEcCtD
Glyburide—Abdominal pain—Methylprednisolone—multiple sclerosis	9.63e-05	0.00127	CcSEcCtD
Glyburide—Decreased appetite—Betamethasone—multiple sclerosis	9.63e-05	0.00127	CcSEcCtD
Glyburide—Decreased appetite—Dexamethasone—multiple sclerosis	9.63e-05	0.00127	CcSEcCtD
Glyburide—Nausea—Mitoxantrone—multiple sclerosis	9.62e-05	0.00127	CcSEcCtD
Glyburide—Gastrointestinal disorder—Betamethasone—multiple sclerosis	9.57e-05	0.00126	CcSEcCtD
Glyburide—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	9.57e-05	0.00126	CcSEcCtD
Glyburide—Shock—Prednisone—multiple sclerosis	9.5e-05	0.00125	CcSEcCtD
Glyburide—Nervous system disorder—Prednisone—multiple sclerosis	9.47e-05	0.00125	CcSEcCtD
Glyburide—Hyperhidrosis—Prednisone—multiple sclerosis	9.33e-05	0.00123	CcSEcCtD
Glyburide—Vision blurred—Methotrexate—multiple sclerosis	9.31e-05	0.00123	CcSEcCtD
Glyburide—Anorexia—Prednisone—multiple sclerosis	9.2e-05	0.00122	CcSEcCtD
Glyburide—Anaemia—Methotrexate—multiple sclerosis	9.13e-05	0.00121	CcSEcCtD
Glyburide—Feeling abnormal—Betamethasone—multiple sclerosis	9.13e-05	0.00121	CcSEcCtD
Glyburide—Feeling abnormal—Dexamethasone—multiple sclerosis	9.13e-05	0.00121	CcSEcCtD
Glyburide—Gastrointestinal pain—Betamethasone—multiple sclerosis	9.06e-05	0.0012	CcSEcCtD
Glyburide—Gastrointestinal pain—Dexamethasone—multiple sclerosis	9.06e-05	0.0012	CcSEcCtD
Glyburide—Hypersensitivity—Triamcinolone—multiple sclerosis	9e-05	0.00119	CcSEcCtD
Glyburide—Hypersensitivity—Methylprednisolone—multiple sclerosis	8.98e-05	0.00119	CcSEcCtD
Glyburide—Leukopenia—Methotrexate—multiple sclerosis	8.85e-05	0.00117	CcSEcCtD
Glyburide—Urticaria—Betamethasone—multiple sclerosis	8.8e-05	0.00116	CcSEcCtD
Glyburide—Urticaria—Dexamethasone—multiple sclerosis	8.8e-05	0.00116	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Prednisone—multiple sclerosis	8.79e-05	0.00116	CcSEcCtD
Glyburide—Asthenia—Triamcinolone—multiple sclerosis	8.76e-05	0.00116	CcSEcCtD
Glyburide—Abdominal pain—Betamethasone—multiple sclerosis	8.76e-05	0.00116	CcSEcCtD
Glyburide—Abdominal pain—Dexamethasone—multiple sclerosis	8.76e-05	0.00116	CcSEcCtD
Glyburide—Asthenia—Methylprednisolone—multiple sclerosis	8.74e-05	0.00116	CcSEcCtD
Glyburide—Paraesthesia—Prednisone—multiple sclerosis	8.67e-05	0.00115	CcSEcCtD
Glyburide—Pruritus—Triamcinolone—multiple sclerosis	8.64e-05	0.00114	CcSEcCtD
Glyburide—Pruritus—Methylprednisolone—multiple sclerosis	8.62e-05	0.00114	CcSEcCtD
Glyburide—Convulsion—Methotrexate—multiple sclerosis	8.56e-05	0.00113	CcSEcCtD
Glyburide—ABCB1—nervous system—multiple sclerosis	8.55e-05	0.00309	CbGeAlD
Glyburide—Dyspepsia—Prednisone—multiple sclerosis	8.5e-05	0.00112	CcSEcCtD
Glyburide—Arthralgia—Methotrexate—multiple sclerosis	8.41e-05	0.00111	CcSEcCtD
Glyburide—Myalgia—Methotrexate—multiple sclerosis	8.41e-05	0.00111	CcSEcCtD
Glyburide—Decreased appetite—Prednisone—multiple sclerosis	8.39e-05	0.00111	CcSEcCtD
Glyburide—Rash—Prednisolone—multiple sclerosis	8.37e-05	0.00111	CcSEcCtD
Glyburide—Dermatitis—Prednisolone—multiple sclerosis	8.37e-05	0.00111	CcSEcCtD
Glyburide—Diarrhoea—Methylprednisolone—multiple sclerosis	8.34e-05	0.0011	CcSEcCtD
Glyburide—Headache—Prednisolone—multiple sclerosis	8.32e-05	0.0011	CcSEcCtD
Glyburide—ABCB1—central nervous system—multiple sclerosis	8.23e-05	0.00297	CbGeAlD
Glyburide—Confusional state—Methotrexate—multiple sclerosis	8.13e-05	0.00107	CcSEcCtD
Glyburide—ABCB1—cerebellum—multiple sclerosis	8.05e-05	0.00291	CbGeAlD
Glyburide—Feeling abnormal—Prednisone—multiple sclerosis	7.95e-05	0.00105	CcSEcCtD
Glyburide—Asthenia—Dexamethasone—multiple sclerosis	7.95e-05	0.00105	CcSEcCtD
Glyburide—Asthenia—Betamethasone—multiple sclerosis	7.95e-05	0.00105	CcSEcCtD
Glyburide—Nervous system disorder—Methotrexate—multiple sclerosis	7.91e-05	0.00105	CcSEcCtD
Glyburide—Thrombocytopenia—Methotrexate—multiple sclerosis	7.9e-05	0.00104	CcSEcCtD
Glyburide—Gastrointestinal pain—Prednisone—multiple sclerosis	7.89e-05	0.00104	CcSEcCtD
Glyburide—Nausea—Prednisolone—multiple sclerosis	7.89e-05	0.00104	CcSEcCtD
Glyburide—Pruritus—Betamethasone—multiple sclerosis	7.84e-05	0.00104	CcSEcCtD
Glyburide—Pruritus—Dexamethasone—multiple sclerosis	7.84e-05	0.00104	CcSEcCtD
Glyburide—Hyperhidrosis—Methotrexate—multiple sclerosis	7.8e-05	0.00103	CcSEcCtD
Glyburide—Vomiting—Triamcinolone—multiple sclerosis	7.77e-05	0.00103	CcSEcCtD
Glyburide—Vomiting—Methylprednisolone—multiple sclerosis	7.75e-05	0.00102	CcSEcCtD
Glyburide—Rash—Triamcinolone—multiple sclerosis	7.7e-05	0.00102	CcSEcCtD
Glyburide—Dermatitis—Triamcinolone—multiple sclerosis	7.69e-05	0.00102	CcSEcCtD
Glyburide—Anorexia—Methotrexate—multiple sclerosis	7.69e-05	0.00102	CcSEcCtD
Glyburide—Rash—Methylprednisolone—multiple sclerosis	7.68e-05	0.00102	CcSEcCtD
Glyburide—Dermatitis—Methylprednisolone—multiple sclerosis	7.68e-05	0.00101	CcSEcCtD
Glyburide—Urticaria—Prednisone—multiple sclerosis	7.67e-05	0.00101	CcSEcCtD
Glyburide—Headache—Triamcinolone—multiple sclerosis	7.65e-05	0.00101	CcSEcCtD
Glyburide—Headache—Methylprednisolone—multiple sclerosis	7.63e-05	0.00101	CcSEcCtD
Glyburide—Abdominal pain—Prednisone—multiple sclerosis	7.63e-05	0.00101	CcSEcCtD
Glyburide—Diarrhoea—Dexamethasone—multiple sclerosis	7.58e-05	0.001	CcSEcCtD
Glyburide—Diarrhoea—Betamethasone—multiple sclerosis	7.58e-05	0.001	CcSEcCtD
Glyburide—Hypotension—Methotrexate—multiple sclerosis	7.54e-05	0.000996	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	7.35e-05	0.000971	CcSEcCtD
Glyburide—Nausea—Triamcinolone—multiple sclerosis	7.26e-05	0.000959	CcSEcCtD
Glyburide—Paraesthesia—Methotrexate—multiple sclerosis	7.24e-05	0.000957	CcSEcCtD
Glyburide—Nausea—Methylprednisolone—multiple sclerosis	7.24e-05	0.000957	CcSEcCtD
Glyburide—Dyspnoea—Methotrexate—multiple sclerosis	7.19e-05	0.00095	CcSEcCtD
Glyburide—Hypersensitivity—Prednisone—multiple sclerosis	7.11e-05	0.00094	CcSEcCtD
Glyburide—Dyspepsia—Methotrexate—multiple sclerosis	7.1e-05	0.000938	CcSEcCtD
Glyburide—Vomiting—Betamethasone—multiple sclerosis	7.05e-05	0.000931	CcSEcCtD
Glyburide—Vomiting—Dexamethasone—multiple sclerosis	7.05e-05	0.000931	CcSEcCtD
Glyburide—Decreased appetite—Methotrexate—multiple sclerosis	7.01e-05	0.000927	CcSEcCtD
Glyburide—Rash—Dexamethasone—multiple sclerosis	6.99e-05	0.000924	CcSEcCtD
Glyburide—Rash—Betamethasone—multiple sclerosis	6.99e-05	0.000924	CcSEcCtD
Glyburide—Dermatitis—Betamethasone—multiple sclerosis	6.98e-05	0.000923	CcSEcCtD
Glyburide—Dermatitis—Dexamethasone—multiple sclerosis	6.98e-05	0.000923	CcSEcCtD
Glyburide—Gastrointestinal disorder—Methotrexate—multiple sclerosis	6.96e-05	0.00092	CcSEcCtD
Glyburide—Headache—Betamethasone—multiple sclerosis	6.94e-05	0.000918	CcSEcCtD
Glyburide—Headache—Dexamethasone—multiple sclerosis	6.94e-05	0.000918	CcSEcCtD
Glyburide—Asthenia—Prednisone—multiple sclerosis	6.92e-05	0.000915	CcSEcCtD
Glyburide—Pruritus—Prednisone—multiple sclerosis	6.83e-05	0.000902	CcSEcCtD
Glyburide—Feeling abnormal—Methotrexate—multiple sclerosis	6.65e-05	0.000878	CcSEcCtD
Glyburide—Diarrhoea—Prednisone—multiple sclerosis	6.6e-05	0.000873	CcSEcCtD
Glyburide—Gastrointestinal pain—Methotrexate—multiple sclerosis	6.6e-05	0.000872	CcSEcCtD
Glyburide—Nausea—Dexamethasone—multiple sclerosis	6.58e-05	0.00087	CcSEcCtD
Glyburide—Nausea—Betamethasone—multiple sclerosis	6.58e-05	0.00087	CcSEcCtD
Glyburide—ABCB1—brain—multiple sclerosis	6.54e-05	0.00236	CbGeAlD
Glyburide—Urticaria—Methotrexate—multiple sclerosis	6.41e-05	0.000847	CcSEcCtD
Glyburide—Abdominal pain—Methotrexate—multiple sclerosis	6.38e-05	0.000843	CcSEcCtD
Glyburide—Vomiting—Prednisone—multiple sclerosis	6.14e-05	0.000811	CcSEcCtD
Glyburide—Rash—Prednisone—multiple sclerosis	6.09e-05	0.000804	CcSEcCtD
Glyburide—Dermatitis—Prednisone—multiple sclerosis	6.08e-05	0.000804	CcSEcCtD
Glyburide—Headache—Prednisone—multiple sclerosis	6.05e-05	0.000799	CcSEcCtD
Glyburide—Hypersensitivity—Methotrexate—multiple sclerosis	5.94e-05	0.000785	CcSEcCtD
Glyburide—Asthenia—Methotrexate—multiple sclerosis	5.79e-05	0.000765	CcSEcCtD
Glyburide—Nausea—Prednisone—multiple sclerosis	5.73e-05	0.000758	CcSEcCtD
Glyburide—Pruritus—Methotrexate—multiple sclerosis	5.71e-05	0.000754	CcSEcCtD
Glyburide—Diarrhoea—Methotrexate—multiple sclerosis	5.52e-05	0.000729	CcSEcCtD
Glyburide—Vomiting—Methotrexate—multiple sclerosis	5.13e-05	0.000678	CcSEcCtD
Glyburide—Rash—Methotrexate—multiple sclerosis	5.09e-05	0.000672	CcSEcCtD
Glyburide—Dermatitis—Methotrexate—multiple sclerosis	5.08e-05	0.000672	CcSEcCtD
Glyburide—Headache—Methotrexate—multiple sclerosis	5.05e-05	0.000668	CcSEcCtD
Glyburide—Nausea—Methotrexate—multiple sclerosis	4.79e-05	0.000633	CcSEcCtD
Glyburide—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	3.53e-05	0.000581	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	3.49e-05	0.000575	CbGpPWpGaD
Glyburide—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.45e-05	0.000568	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—SRM—multiple sclerosis	3.4e-05	0.000561	CbGpPWpGaD
Glyburide—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	3.36e-05	0.000554	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.34e-05	0.00055	CbGpPWpGaD
Glyburide—ABCA1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.3e-05	0.000544	CbGpPWpGaD
Glyburide—CPT1A—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.3e-05	0.000544	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.3e-05	0.000544	CbGpPWpGaD
Glyburide—CPT1A—Circadian rythm related genes—IL6—multiple sclerosis	3.3e-05	0.000544	CbGpPWpGaD
Glyburide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.26e-05	0.000536	CbGpPWpGaD
Glyburide—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.24e-05	0.000534	CbGpPWpGaD
Glyburide—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	3.2e-05	0.000527	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—CYP24A1—multiple sclerosis	3.19e-05	0.000526	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—CYP27B1—multiple sclerosis	3.19e-05	0.000526	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	3.19e-05	0.000525	CbGpPWpGaD
Glyburide—SLC15A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.13e-05	0.000516	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.12e-05	0.000514	CbGpPWpGaD
Glyburide—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	3.12e-05	0.000514	CbGpPWpGaD
Glyburide—SLC22A7—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.08e-05	0.000507	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—IFNG—multiple sclerosis	3.07e-05	0.000505	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—CYP27B1—multiple sclerosis	3.06e-05	0.000504	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—RRM1—multiple sclerosis	3.06e-05	0.000504	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—CYP24A1—multiple sclerosis	3.06e-05	0.000504	CbGpPWpGaD
Glyburide—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.05e-05	0.000502	CbGpPWpGaD
Glyburide—CPT1A—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.01e-05	0.000496	CbGpPWpGaD
Glyburide—ABCA1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.01e-05	0.000496	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—SRM—multiple sclerosis	3e-05	0.000494	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.99e-05	0.000493	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.99e-05	0.000493	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—RRM1—multiple sclerosis	2.97e-05	0.000489	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.95e-05	0.000486	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—CD80—multiple sclerosis	2.94e-05	0.000485	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.92e-05	0.000482	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.92e-05	0.000482	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—GPC5—multiple sclerosis	2.92e-05	0.000481	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.92e-05	0.000481	CbGpPWpGaD
Glyburide—SLC15A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.91e-05	0.000479	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.9e-05	0.000478	CbGpPWpGaD
Glyburide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.9e-05	0.000477	CbGpPWpGaD
Glyburide—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	2.87e-05	0.000472	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—BCHE—multiple sclerosis	2.85e-05	0.000469	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—BCHE—multiple sclerosis	2.85e-05	0.000469	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—GPC5—multiple sclerosis	2.8e-05	0.000461	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—IL1B—multiple sclerosis	2.74e-05	0.000451	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—IL2—multiple sclerosis	2.73e-05	0.000449	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—CYP24A1—multiple sclerosis	2.67e-05	0.000439	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—CYP27B1—multiple sclerosis	2.67e-05	0.000439	CbGpPWpGaD
Glyburide—ABCC3—NRF2 pathway—TGFB1—multiple sclerosis	2.65e-05	0.000436	CbGpPWpGaD
Glyburide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.64e-05	0.000435	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.63e-05	0.000433	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.63e-05	0.000433	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.62e-05	0.000432	CbGpPWpGaD
Glyburide—ABCC1—Disease—GPC5—multiple sclerosis	2.62e-05	0.000432	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PLEK—multiple sclerosis	2.62e-05	0.000431	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.61e-05	0.000429	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.57e-05	0.000423	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	2.55e-05	0.00042	CbGpPWpGaD
Glyburide—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	2.44e-05	0.000402	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—GPC5—multiple sclerosis	2.44e-05	0.000402	CbGpPWpGaD
Glyburide—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	2.44e-05	0.000401	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—RRM1—multiple sclerosis	2.42e-05	0.000399	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CYP27B1—multiple sclerosis	2.4e-05	0.000395	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CYP24A1—multiple sclerosis	2.4e-05	0.000395	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.39e-05	0.000394	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.39e-05	0.000394	CbGpPWpGaD
Glyburide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	2.37e-05	0.00039	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.34e-05	0.000386	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	2.33e-05	0.000383	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—RRM1—multiple sclerosis	2.32e-05	0.000382	CbGpPWpGaD
Glyburide—SLCO1A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.3e-05	0.000378	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.27e-05	0.000373	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—GPC5—multiple sclerosis	2.19e-05	0.000361	CbGpPWpGaD
Glyburide—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	2.17e-05	0.000358	CbGpPWpGaD
Glyburide—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.16e-05	0.000356	CbGpPWpGaD
Glyburide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.15e-05	0.000354	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CYP27B1—multiple sclerosis	2.11e-05	0.000348	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CYP24A1—multiple sclerosis	2.11e-05	0.000348	CbGpPWpGaD
Glyburide—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	2.1e-05	0.000346	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	2.08e-05	0.000342	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—IL2—multiple sclerosis	2.07e-05	0.000341	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.05e-05	0.000337	CbGpPWpGaD
Glyburide—ABCC8—Neuronal System—MAPK1—multiple sclerosis	2.04e-05	0.000336	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—RRM1—multiple sclerosis	2.02e-05	0.000333	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.99e-05	0.000327	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—TNF—multiple sclerosis	1.98e-05	0.000327	CbGpPWpGaD
Glyburide—KCNJ11—Neuronal System—MAPK1—multiple sclerosis	1.98e-05	0.000326	CbGpPWpGaD
Glyburide—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	1.97e-05	0.000324	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GPC5—multiple sclerosis	1.93e-05	0.000318	CbGpPWpGaD
Glyburide—SLCO2B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.9e-05	0.000313	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.88e-05	0.000309	CbGpPWpGaD
Glyburide—ALB—Metabolism—SRM—multiple sclerosis	1.85e-05	0.000305	CbGpPWpGaD
Glyburide—ALB—Hemostasis—SELE—multiple sclerosis	1.84e-05	0.000304	CbGpPWpGaD
Glyburide—ALB—Platelet degranulation—TGFB1—multiple sclerosis	1.82e-05	0.0003	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—RRM1—multiple sclerosis	1.82e-05	0.000299	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.8e-05	0.000297	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.79e-05	0.000295	CbGpPWpGaD
Glyburide—ABCC8—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.77e-05	0.000291	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	1.77e-05	0.000291	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—BCHE—multiple sclerosis	1.76e-05	0.00029	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.75e-05	0.000288	CbGpPWpGaD
Glyburide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.74e-05	0.000287	CbGpPWpGaD
Glyburide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	1.74e-05	0.000286	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—APOE—multiple sclerosis	1.71e-05	0.000282	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—APOE—multiple sclerosis	1.71e-05	0.000282	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—BCHE—multiple sclerosis	1.7e-05	0.000281	CbGpPWpGaD
Glyburide—ABCC1—Disease—RPL5—multiple sclerosis	1.7e-05	0.000281	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SRM—multiple sclerosis	1.66e-05	0.000273	CbGpPWpGaD
Glyburide—ABCC1—Disease—SLC11A1—multiple sclerosis	1.63e-05	0.000269	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SRM—multiple sclerosis	1.62e-05	0.000267	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	1.61e-05	0.000266	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.61e-05	0.000266	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—IL6—multiple sclerosis	1.6e-05	0.000264	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—RRM1—multiple sclerosis	1.6e-05	0.000264	CbGpPWpGaD
Glyburide—SLC15A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.59e-05	0.000262	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.58e-05	0.000261	CbGpPWpGaD
Glyburide—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	1.58e-05	0.00026	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.57e-05	0.000259	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.57e-05	0.000258	CbGpPWpGaD
Glyburide—SLC22A7—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.56e-05	0.000258	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.55e-05	0.000255	CbGpPWpGaD
Glyburide—CYP2C19—Biological oxidations—POMC—multiple sclerosis	1.54e-05	0.000253	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SRM—multiple sclerosis	1.51e-05	0.000249	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—TNF—multiple sclerosis	1.51e-05	0.000248	CbGpPWpGaD
Glyburide—SLC15A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.48e-05	0.000243	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—POMC—multiple sclerosis	1.47e-05	0.000242	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—POMC—multiple sclerosis	1.47e-05	0.000242	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.47e-05	0.000242	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.41e-05	0.000232	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.41e-05	0.000232	CbGpPWpGaD
Glyburide—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.4e-05	0.000231	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—BCHE—multiple sclerosis	1.39e-05	0.000229	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.39e-05	0.000229	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.35e-05	0.000222	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—ALB—multiple sclerosis	1.34e-05	0.000221	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—ALB—multiple sclerosis	1.34e-05	0.000221	CbGpPWpGaD
Glyburide—ABCC3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.34e-05	0.000221	CbGpPWpGaD
Glyburide—ALB—Hemostasis—ITGA4—multiple sclerosis	1.33e-05	0.00022	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—BCHE—multiple sclerosis	1.33e-05	0.00022	CbGpPWpGaD
Glyburide—ALB—Hemostasis—IFNB1—multiple sclerosis	1.32e-05	0.000218	CbGpPWpGaD
Glyburide—ABCC1—Disease—CD28—multiple sclerosis	1.3e-05	0.000215	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP24A1—multiple sclerosis	1.3e-05	0.000215	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP27B1—multiple sclerosis	1.3e-05	0.000215	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.27e-05	0.00021	CbGpPWpGaD
Glyburide—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	1.27e-05	0.00021	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.23e-05	0.000202	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.21e-05	0.0002	CbGpPWpGaD
Glyburide—ALB—Metabolism—GPC5—multiple sclerosis	1.19e-05	0.000196	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.17e-05	0.000193	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.17e-05	0.000193	CbGpPWpGaD
Glyburide—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.17e-05	0.000192	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—BCHE—multiple sclerosis	1.16e-05	0.000191	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.14e-05	0.000188	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.14e-05	0.000188	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.14e-05	0.000188	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.1e-05	0.000182	CbGpPWpGaD
Glyburide—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.1e-05	0.000181	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.07e-05	0.000176	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.07e-05	0.000176	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.07e-05	0.000176	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.06e-05	0.000175	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—APOE—multiple sclerosis	1.06e-05	0.000174	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.05e-05	0.000173	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—BCHE—multiple sclerosis	1.04e-05	0.000172	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GPC5—multiple sclerosis	1.04e-05	0.000172	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.04e-05	0.000172	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.04e-05	0.000171	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—APOE—multiple sclerosis	1.03e-05	0.000169	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SRM—multiple sclerosis	9.98e-06	0.000164	CbGpPWpGaD
Glyburide—ALB—Metabolism—RRM1—multiple sclerosis	9.87e-06	0.000163	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GPC5—multiple sclerosis	9.75e-06	0.000161	CbGpPWpGaD
Glyburide—ABCC1—Disease—CD86—multiple sclerosis	9.29e-06	0.000153	CbGpPWpGaD
Glyburide—CYP3A4—Biological oxidations—POMC—multiple sclerosis	9.25e-06	0.000152	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.24e-06	0.000152	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—BCHE—multiple sclerosis	9.19e-06	0.000151	CbGpPWpGaD
Glyburide—ALB—Hemostasis—IL2RA—multiple sclerosis	9.11e-06	0.00015	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—POMC—multiple sclerosis	9.09e-06	0.00015	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—RRM1—multiple sclerosis	8.86e-06	0.000146	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—POMC—multiple sclerosis	8.81e-06	0.000145	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—RRM1—multiple sclerosis	8.65e-06	0.000142	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—APOE—multiple sclerosis	8.36e-06	0.000138	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—ALB—multiple sclerosis	8.28e-06	0.000136	CbGpPWpGaD
Glyburide—ABCC1—Disease—CCR5—multiple sclerosis	8.24e-06	0.000136	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	8.08e-06	0.000133	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—RRM1—multiple sclerosis	8.08e-06	0.000133	CbGpPWpGaD
Glyburide—ABCC1—Disease—HLA-A—multiple sclerosis	8.03e-06	0.000132	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—ALB—multiple sclerosis	8.03e-06	0.000132	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—APOE—multiple sclerosis	8.02e-06	0.000132	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	7.98e-06	0.000131	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	7.96e-06	0.000131	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	7.93e-06	0.000131	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	7.81e-06	0.000129	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.66e-06	0.000126	CbGpPWpGaD
Glyburide—ABCC1—Disease—APOE—multiple sclerosis	7.5e-06	0.000124	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	7.43e-06	0.000122	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—POMC—multiple sclerosis	7.18e-06	0.000118	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	7.03e-06	0.000116	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	7.03e-06	0.000116	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—APOE—multiple sclerosis	6.98e-06	0.000115	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—POMC—multiple sclerosis	6.89e-06	0.000113	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.87e-06	0.000113	CbGpPWpGaD
Glyburide—ABCC1—Disease—CD80—multiple sclerosis	6.78e-06	0.000112	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.58e-06	0.000108	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—ALB—multiple sclerosis	6.55e-06	0.000108	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GPC5—multiple sclerosis	6.43e-06	0.000106	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—APOE—multiple sclerosis	6.28e-06	0.000103	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—ALB—multiple sclerosis	6.28e-06	0.000103	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.27e-06	0.000103	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—POMC—multiple sclerosis	6e-06	9.88e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.91e-06	9.73e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—TYK2—multiple sclerosis	5.72e-06	9.43e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—BCHE—multiple sclerosis	5.67e-06	9.34e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—APOE—multiple sclerosis	5.53e-06	9.11e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—ALB—multiple sclerosis	5.47e-06	9.01e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—POMC—multiple sclerosis	5.4e-06	8.89e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.38e-06	8.87e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.38e-06	8.87e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—IL2—multiple sclerosis	5.34e-06	8.8e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—RRM1—multiple sclerosis	5.33e-06	8.78e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CD4—multiple sclerosis	5.18e-06	8.53e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—BCHE—multiple sclerosis	5.09e-06	8.38e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	5e-06	8.23e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—BCHE—multiple sclerosis	4.97e-06	8.18e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ALB—multiple sclerosis	4.92e-06	8.1e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.91e-06	8.09e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—POMC—multiple sclerosis	4.75e-06	7.82e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—BCHE—multiple sclerosis	4.64e-06	7.64e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ALB—multiple sclerosis	4.33e-06	7.13e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TGFB1—multiple sclerosis	4.17e-06	6.86e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—MAPK1—multiple sclerosis	4.09e-06	6.73e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—STAT3—multiple sclerosis	4.01e-06	6.6e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MYC—multiple sclerosis	3.72e-06	6.14e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—TGFB1—multiple sclerosis	3.72e-06	6.12e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MAPK1—multiple sclerosis	3.64e-06	6e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—APOE—multiple sclerosis	3.41e-06	5.62e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—APOE—multiple sclerosis	3.06e-06	5.04e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.06e-06	5.04e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—APOE—multiple sclerosis	2.99e-06	4.92e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—POMC—multiple sclerosis	2.93e-06	4.83e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—IL6—multiple sclerosis	2.8e-06	4.61e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—APOE—multiple sclerosis	2.79e-06	4.6e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—POMC—multiple sclerosis	2.63e-06	4.33e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—POMC—multiple sclerosis	2.57e-06	4.23e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—POMC—multiple sclerosis	2.4e-06	3.95e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ALB—multiple sclerosis	2.4e-06	3.95e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ALB—multiple sclerosis	2.34e-06	3.86e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ALB—multiple sclerosis	2.19e-06	3.6e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—APOE—multiple sclerosis	1.84e-06	3.03e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—POMC—multiple sclerosis	1.58e-06	2.61e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ALB—multiple sclerosis	1.44e-06	2.38e-05	CbGpPWpGaD
